IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis.

[1]  K. Meldrum,et al.  TNF-α neutralization ameliorates obstruction-induced renal fibrosis and dysfunction , 2007 .

[2]  D. Poppas,et al.  Effect of combination therapy with enalapril and the TGF-β antagonist 1D11 in unilateral ureteral obstruction , 2007 .

[3]  Hua-feng Liu,et al.  Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells , 2007, Nephrology.

[4]  M. Rastaldi.  Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. , 2006, Journal of nephrology.

[5]  R. Chevalier,et al.  Obstructive nephropathy: towards biomarker discovery and gene therapy , 2006, Nature Clinical Practice Nephrology.

[6]  James W. Thomas,et al.  Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. , 2005, Kidney international.

[7]  Marek Ancukiewicz,et al.  Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. , 2005, Journal of the American Society of Nephrology : JASN.

[8]  J. Lácha,et al.  Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. , 2005, Immunology letters.

[9]  Hua-feng Liu,et al.  [Expressions of IL-18Ralpha and IL-18Rbeta on rat primary renal tubular epithelial cells]. , 2005, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[10]  H. Moses,et al.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.

[11]  K. Meldrum,et al.  Inflammatory mediators and growth factors in obstructive renal injury. , 2004, The Journal of surgical research.

[12]  E. Neilson,et al.  Mechanisms of tubulointerstitial fibrosis. , 1991, Kidney international.

[13]  C. Edelstein,et al.  Urinary interleukin-18 is a marker of human acute tubular necrosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Andrea Vondracek,et al.  Generation and characterization of mice transgenic for human IL‐18‐binding protein isoform a , 2003, Journal of leukocyte biology.

[15]  Junwei Yang,et al.  Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis , 2003 .

[16]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[17]  R. Fine,et al.  Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS , 2003, Pediatric Nephrology.

[18]  D. Lovett,et al.  Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. , 2003, The American journal of pathology.

[19]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[20]  Gábor Sirokmány,et al.  Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition , 2003 .

[21]  S. Klahr,et al.  Progression of chronic renal disease. , 2003, Heart disease.

[22]  J. Kriegsmann,et al.  Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. , 2002, Arthritis and rheumatism.

[23]  C. Edelstein,et al.  Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. , 2002, The Journal of clinical investigation.

[24]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[25]  R. Kalluri,et al.  Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. , 2002, Kidney international.

[26]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[27]  R. Kalluri,et al.  Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. , 2001, The American journal of pathology.

[28]  S. Klahr,et al.  Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis , 2001 .

[29]  M. Lucia,et al.  Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. , 2001, The Journal of clinical investigation.

[30]  D. Poppas,et al.  Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. , 2000, Kidney international.

[31]  L. Joosten,et al.  Neutralization of IL-18 Reduces Neutrophil Tissue Accumulation and Protects Mice Against Lethal Escherichia coli and Salmonella typhimurium Endotoxemia1 , 2000, The Journal of Immunology.

[32]  S. Klahr,et al.  Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. , 1999, American journal of physiology. Renal physiology.

[33]  W. Buurman,et al.  Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. , 1999, Journal of Immunology.

[34]  M. Lotz,et al.  IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. , 1999, Journal of immunology.

[35]  R. Barraclough.  Calcium-binding protein S100A4 in health and disease. , 1998, Biochimica et biophysica acta.

[36]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[37]  E. Healy,et al.  Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. , 1998, Current opinion in nephrology and hypertension.

[38]  R. Atkins,et al.  Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. , 1998, Kidney international.

[39]  G. Fantuzzi,et al.  Overview of interleukin‐18: more than an interferon‐γ inducing factor , 1998, Journal of leukocyte biology.

[40]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[41]  J. Heesemann,et al.  IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. , 1998, Journal of immunology.

[42]  E. Bongcam-Rudloff,et al.  Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. , 1997, Cancer research.

[43]  H. Kolb,et al.  Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. , 1997, The Journal of clinical investigation.

[44]  A. Eddy.  Molecular insights into renal interstitial fibrosis. , 1996, Journal of the American Society of Nephrology : JASN.

[45]  F. Strutz,et al.  Transdifferentiation: a new angle on renal fibrosis. , 1996, Experimental nephrology.

[46]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[47]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[48]  S. Klahr,et al.  Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. , 1994, Kidney international.

[49]  G. Becker,et al.  Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. , 1993, Kidney international.

[50]  H. Humes,et al.  Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. , 1992, Experimental cell research.

[51]  M. Sporn,et al.  TGF-β: Regulation of extracellular matrix , 1992 .

[52]  E. Neilson,et al.  Mechanisms of tubulointerstitial fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[53]  S. Klahr,et al.  Progression of chronic renal disease. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  A. Harvey,et al.  Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. , 1988, Biochemical and biophysical research communications.

[55]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, The Journal of experimental medicine.

[56]  Junwei Yang,et al.  Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. , 2002, Journal of the American Society of Nephrology : JASN.

[57]  R. Atkins,et al.  Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. , 1999, Kidney international.

[58]  S. Klahr,et al.  Angiotensin II and gene expression in the kidney. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  T. Haverty,et al.  Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. , 1992, Kidney international.